IN8bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-30.01	-28.52	-14.65	-10.34	-5.91
Depreciation & Amortization	2.5	1.1	0.79	0.09	0.1
Share-Based Compensation	4.37	3.47	2.2	0.36	0.08
Other Operating Activities	-0.2	-0.17	-1.84	2.76	0.94
Operating Cash Flow	-23.34	-24.12	-13.51	-7.13	-4.8
Capital Expenditures	-0.6	-3.71	-0.31	0	0.36
Investing Cash Flow	-0.6	-3.71	-0.31	0	0.36
Share Issuance / Repurchase	27.84	9.6	36.36	0.51	0.07
Debt Issued / Paid	-0.8	-0.62	-0.71	0.17	0
Other Financing Activities	-	-	-2.69	23.83	-
Financing Cash Flow	27.04	8.99	32.96	24.52	0.07
Net Cash Flow	3.1	-18.84	19.14	17.38	-4.38
Free Cash Flow	-23.94	-27.83	-13.82	-7.13	-4.45
Free Cash Flow Per Share	-0.80	-1.33	-1.39	-2.09	-1.39

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).